Cita APA

Chen, K., Chen, H., Shiau, C., Liu, C., Chu, P., Tai, W., . . . Cheng, A. (2013). Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody. Blackwell Publishing Ltd.

Citación estilo Chicago

Chen, Kuen-Feng, Hui-Ling Chen, Chung-Wai Shiau, Chun-Yu Liu, Pei-Yi Chu, Wei-Tien Tai, Kimihisa Ichikawa, Pei-Jer Chen, y Ann-Lii Cheng. Sorafenib and Its Derivative SC-49 Sensitize Hepatocellular Carcinoma Cells to CS-1008, a Humanized Anti-TNFRSF10B (DR5) Antibody. Blackwell Publishing Ltd, 2013.

Cita MLA

Chen, Kuen-Feng, et al. Sorafenib and Its Derivative SC-49 Sensitize Hepatocellular Carcinoma Cells to CS-1008, a Humanized Anti-TNFRSF10B (DR5) Antibody. Blackwell Publishing Ltd, 2013.